2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …
N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of …
The American Diabetes Association (ADA) and the European Association for the Study of
Diabetes (EASD) convened a writing group to develop a consensus statement on the …
Diabetes (EASD) convened a writing group to develop a consensus statement on the …
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
CX Ma, XN Ma, CH Guan, YD Li, D Mauricio… - Cardiovascular …, 2022 - Springer
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2
diabetes mellitus (T2DM), particularly in low-and middle-income countries. To effectively …
diabetes mellitus (T2DM), particularly in low-and middle-income countries. To effectively …
Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications
E Papachristoforou, V Lambadiari… - Journal of diabetes …, 2020 - Wiley Online Library
Oxidative stress (OS) is defined as a disturbance in the prooxidant‐antioxidant balance of
the cell, in favor of the former, which results in the antioxidant capacity of the cell to be …
the cell, in favor of the former, which results in the antioxidant capacity of the cell to be …
Electrochemical non-enzymatic glucose sensors: recent progress and perspectives
M Wei, Y Qiao, H Zhao, J Liang, T Li, Y Luo… - Chemical …, 2020 - pubs.rsc.org
The detection of glucose has important significance in clinical medicine and the food
industry, especially in the diagnosis of diabetes. In recent years, electrochemical non …
industry, especially in the diagnosis of diabetes. In recent years, electrochemical non …
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic …
L Mazzolai, G Teixido-Tura, S Lanzi, V Boc… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial
AB Daly, CK Boughton, M Nwokolo, S Hartnell… - Nature medicine, 2023 - nature.com
In adults with type 2 diabetes, the benefits of fully closed-loop insulin delivery, which does
not require meal bolusing, are unclear. In an open-label, single-center, randomized …
not require meal bolusing, are unclear. In an open-label, single-center, randomized …
The consequences of hypoglycaemia
SA Amiel - Diabetologia, 2021 - Springer
Hypoglycaemia (blood glucose concentration below the normal range) has been recognised
as a complication of insulin treatment from the very first days of the discovery of insulin, and …
as a complication of insulin treatment from the very first days of the discovery of insulin, and …
[HTML][HTML] Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention
A Nakhleh, N Shehadeh - World journal of diabetes, 2021 - ncbi.nlm.nih.gov
Hypoglycemia is a common complication in patients with diabetes, mainly in those treated
with insulin, sulfonylurea, or glinide. Impairments in counterregulatory responses and …
with insulin, sulfonylurea, or glinide. Impairments in counterregulatory responses and …
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
MM Zhao, J Lu, S Li, H Wang, X Cao, Q Li… - Nature …, 2021 - nature.com
Coptis chinensis is an ancient Chinese herb treating diabetes in China for thousands of
years. However, its underlying mechanism remains poorly understood. Here, we report the …
years. However, its underlying mechanism remains poorly understood. Here, we report the …